Guardant Health Inc (NASDAQ: GH) on Friday, soared 6.25% from the previous trading day, before settling in for the closing price of $41.14. Within the past 52 weeks, GH’s price has moved between $15.81 and $50.89.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 28.17% over the last five years. The company achieved an average annual earnings per share of 18.55%. With a float of $117.04 million, this company’s outstanding shares have now reached $123.99 million.
The firm has a total of 2021 workers. Let’s measure their productivity. In terms of profitability, gross margin is 60.79%, operating margin of -60.02%, and the pretax margin is -58.87%.
Guardant Health Inc (GH) Breakdown of a Key Holders of the stock
Observing investor behavior towards Diagnostics & Research industry stocks is more important than anything else. The insider ownership of Guardant Health Inc is 5.17%, while institutional ownership is 96.17%. The most recent insider transaction that took place on Mar 19 ’25, was worth 5,069. In this transaction Director of this company sold 116 shares at a rate of $43.70, taking the stock ownership to the 3,211 shares. Before that another transaction happened on Mar 19 ’25, when Company’s Director proposed sale 116 for $43.70, making the entire transaction worth $5,069.
Guardant Health Inc (GH) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.55 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 18.55% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 16.98% during the next five years compared to -33.61% drop over the previous five years of trading.
Guardant Health Inc (NASDAQ: GH) Trading Performance Indicators
Guardant Health Inc (GH) is currently performing well based on its current performance indicators. A quick ratio of 4.36 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.30.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.56, a number that is poised to hit -0.75 in the next quarter and is forecasted to reach -2.47 in one year’s time.
Technical Analysis of Guardant Health Inc (GH)
Analysing the last 5-days average volume posted by the [Guardant Health Inc, GH], we can find that recorded value of 2.48 million was better than the volume posted last year of 2.34 million. As of the previous 9 days, the stock’s Stochastic %D was 69.82%. Additionally, its Average True Range was 3.45.
During the past 100 days, Guardant Health Inc’s (GH) raw stochastic average was set at 68.00%, which indicates a significant increase from 62.18% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 68.00% in the past 14 days, which was lower than the 71.83% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $43.77, while its 200-day Moving Average is $33.33. Now, the first resistance to watch is $44.84. This is followed by the second major resistance level at $45.97. The third major resistance level sits at $48.01. If the price goes on to break the first support level at $41.67, it is likely to go to the next support level at $39.63. Now, if the price goes above the second support level, the third support stands at $38.50.
Guardant Health Inc (NASDAQ: GH) Key Stats
Market capitalization of the company is 5.39 billion based on 123,421K outstanding shares. Right now, sales total 739,020 K and income totals -436,370 K. The company made 201,810 K in profit during its latest quarter, and -111,010 K in sales during its previous quarter.
